Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L17 pseudogene 25 (RPL17P25) is a processed pseudogene of the ribosomal protein L17 gene (RPL17) found in the human genome[5][13][17]. Pseudogenes like RPL17P25 are DNA sequences similar to protein-coding genes, but are generally considered non-functional due to mutations preventing them from producing active proteins[4][12]. RPL17 encodes a structural component of the large 60S ribosomal subunit, but RPL17P25 itself is not translated into a functional protein and has no known biological, clinical, or therapeutic relevance. There is no established role for this pseudogene in disease or drug interaction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L17 pseudogene 25 (RPL17P25).